These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 25246709)
1. Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells. Corominas-Faja B; Cuyàs E; Gumuzio J; Bosch-Barrera J; Leis O; Martin ÁG; Menendez JA Oncotarget; 2014 Sep; 5(18):8306-16. PubMed ID: 25246709 [TBL] [Abstract][Full Text] [Related]
2. Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells. Beckers A; Organe S; Timmermans L; Scheys K; Peeters A; Brusselmans K; Verhoeven G; Swinnen JV Cancer Res; 2007 Sep; 67(17):8180-7. PubMed ID: 17804731 [TBL] [Abstract][Full Text] [Related]
3. Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer. Kim JY; Cho Y; Oh E; Lee N; An H; Sung D; Cho TM; Seo JH Cancer Lett; 2016 Aug; 379(1):39-48. PubMed ID: 27238567 [TBL] [Abstract][Full Text] [Related]
4. HER2 overexpression-mediated inflammatory signaling enhances mammosphere formation through up-regulation of aryl hydrocarbon receptor transcription. Zhao S; Ohara S; Kanno Y; Midorikawa Y; Nakayama M; Makimura M; Park Y; Inouye Y Cancer Lett; 2013 Mar; 330(1):41-8. PubMed ID: 23196063 [TBL] [Abstract][Full Text] [Related]
6. Up-regulation of acetyl-CoA carboxylase alpha and fatty acid synthase by human epidermal growth factor receptor 2 at the translational level in breast cancer cells. Yoon S; Lee MY; Park SW; Moon JS; Koh YK; Ahn YH; Park BW; Kim KS J Biol Chem; 2007 Sep; 282(36):26122-31. PubMed ID: 17631500 [TBL] [Abstract][Full Text] [Related]
7. Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation. Jump DB; Torres-Gonzalez M; Olson LK Biochem Pharmacol; 2011 Mar; 81(5):649-60. PubMed ID: 21184748 [TBL] [Abstract][Full Text] [Related]
8. Identification of the yeast ACC1 gene product (acetyl-CoA carboxylase) as the target of the polyketide fungicide soraphen A. Vahlensieck HF; Pridzun L; Reichenbach H; Hinnen A Curr Genet; 1994 Feb; 25(2):95-100. PubMed ID: 7916271 [TBL] [Abstract][Full Text] [Related]
9. Targeting de novo lipogenesis as a novel approach in anti-cancer therapy. Stoiber K; Nagło O; Pernpeintner C; Zhang S; Koeberle A; Ulrich M; Werz O; Müller R; Zahler S; Lohmüller T; Feldmann J; Braig S Br J Cancer; 2018 Jan; 118(1):43-51. PubMed ID: 29112683 [TBL] [Abstract][Full Text] [Related]
10. The telomerase inhibitor imetelstat alone, and in combination with trastuzumab, decreases the cancer stem cell population and self-renewal of HER2+ breast cancer cells. Koziel JE; Herbert BS Breast Cancer Res Treat; 2015 Feb; 149(3):607-18. PubMed ID: 25627551 [TBL] [Abstract][Full Text] [Related]
11. Dihydrotanshinone-Induced NOX5 Activation Inhibits Breast Cancer Stem Cell through the ROS/Stat3 Signaling Pathway. Kim SL; Choi HS; Kim JH; Jeong DK; Kim KS; Lee DS Oxid Med Cell Longev; 2019; 2019():9296439. PubMed ID: 31019654 [TBL] [Abstract][Full Text] [Related]
12. A mechanism for the potent inhibition of eukaryotic acetyl-coenzyme A carboxylase by soraphen A, a macrocyclic polyketide natural product. Shen Y; Volrath SL; Weatherly SC; Elich TD; Tong L Mol Cell; 2004 Dec; 16(6):881-91. PubMed ID: 15610732 [TBL] [Abstract][Full Text] [Related]
13. Expression and characterization of recombinant fungal acetyl-CoA carboxylase and isolation of a soraphen-binding domain. Weatherly SC; Volrath SL; Elich TD Biochem J; 2004 May; 380(Pt 1):105-10. PubMed ID: 14766011 [TBL] [Abstract][Full Text] [Related]
15. The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells. Vazquez-Martin A; Oliveras-Ferraros C; Del Barco S; Martin-Castillo B; Menendez JA Breast Cancer Res Treat; 2011 Apr; 126(2):355-64. PubMed ID: 20458531 [TBL] [Abstract][Full Text] [Related]
16. Stem cell-like ALDH(bright) cellular states in EGFR-mutant non-small cell lung cancer: a novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin. Corominas-Faja B; Oliveras-Ferraros C; Cuyàs E; Segura-Carretero A; Joven J; Martin-Castillo B; Barrajón-Catalán E; Micol V; Bosch-Barrera J; Menendez JA Cell Cycle; 2013 Nov; 12(21):3390-404. PubMed ID: 24047698 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of acetyl-CoA carboxylases by soraphen A prevents lipid accumulation and adipocyte differentiation in 3T3-L1 cells. Cordonier EL; Jarecke SK; Hollinger FE; Zempleni J Eur J Pharmacol; 2016 Jun; 780():202-8. PubMed ID: 27041646 [TBL] [Abstract][Full Text] [Related]
18. Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab. Luo J; Hong Y; Lu Y; Qiu S; Chaganty BK; Zhang L; Wang X; Li Q; Fan Z Cancer Lett; 2017 Jan; 384():39-49. PubMed ID: 27693630 [TBL] [Abstract][Full Text] [Related]
19. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Berod L; Friedrich C; Nandan A; Freitag J; Hagemann S; Harmrolfs K; Sandouk A; Hesse C; Castro CN; Bähre H; Tschirner SK; Gorinski N; Gohmert M; Mayer CT; Huehn J; Ponimaskin E; Abraham WR; Müller R; Lochner M; Sparwasser T Nat Med; 2014 Nov; 20(11):1327-33. PubMed ID: 25282359 [TBL] [Abstract][Full Text] [Related]
20. mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells. Karthik GM; Ma R; Lövrot J; Kis LL; Lindh C; Blomquist L; Fredriksson I; Bergh J; Hartman J Cancer Lett; 2015 Oct; 367(1):76-87. PubMed ID: 26208432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]